Stock comparison
ELI LILLY & Co is 209.6x more valuable than Oruka Therapeutics, Inc. by market capitalization ($1.282 T vs $6.11 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 209.6x more valuable than Oruka Therapeutics, Inc. by market capitalization ($1.282 T vs $6.11 B).
Market value leader
LLY
ELI LILLY & Co is 209.6x more valuable than Oruka Therapeutics, Inc. by market capitalization ($1.282 T vs $6.11 B).
Revenue leader
LLY
ORKA: $0.00 vs LLY: $65.18B.
Profit leader
LLY
ORKA: -$105.43M vs LLY: $20.64B.
| Metric | ORKA | LLY |
|---|---|---|
| Market cap | $6.11 B | $1.282 T |
| US-listed rank | #1242 | #10 |
| Revenue (latest FY) | $0.00 | $65.18B |
| Net income (latest FY) | -$105.43M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 62.1x |
| SEC filings | 1,468 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 209.6x more valuable than Oruka Therapeutics, Inc. by market capitalization ($1.282 T vs $6.11 B).
Full pages: Oruka Therapeutics, Inc. and ELI LILLY & Co, or browse the full rankings.